The Role of Food and Alcohol with Levitra 20 mg

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

• Levitra 20 mg Bayer is popular for its reliability and quick action.
• It’s important to read the patient information leaflet thoroughly.
• This medication is not suitable for children or minors.
• Levitra can sometimes cause a drop in blood pressure.
• Do not combine Levitra with recreational drugs like poppers.
• Men should avoid alcohol for optimal medication efficacy.
• Levitra 20 mg Bayer may be part of a broader cardiovascular assessment.
• Sexual activity should only be undertaken when fully prepared.
• Abstain from heavy physical activity immediately after taking the pill.
• Levitra does not cure underlying causes of erectile dysfunction.
• Always consult a healthcare professional for persistent ED symptoms.

Efficacy of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA treatment improved the patient's erectiondate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA improved the patient's erection after Minimum and Maximum Intervals between LEVITRA intake and the start of intercoursedate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Reporting a second successful intercourse within 24 hours of dosingdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Patients prefer LEVITRA over last Erectile Dysfunction treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Tolerability of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionYesSafety Issue: )]TJ /C2_0 1 Tf 0 Tc 0 Tw 7.98 0 0 7.98 49.405 366.8227 Tm <004A>Tj /TT1 1 Tf 12 0 0 12 52.705 361.3027 Tm ( )Tj /TT0 1 Tf 0.0001 Tc -0.0001 Tw 0.28 0 Td ( Flexible dose studies started all )Tj 0 Tc 0 Tw 13.055 0 Td [(patients at LEVITRA 10 m)7.8 (g)-5 ( and allo)]TJ -0.0002 Tc -0.0005 Tw 14.83 0 Td (wed decrease in dose to 5 mg or )Tj 0.0001 Tc -0.0001 Tw -27.66 -1.145 Td (increase in dose to 20 mg based on side effects and efficacy.

What is Levitra?

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Efficacy of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA treatment improved the patient's erectiondate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: LEVITRA improved the patient's erection after Minimum and Maximum Intervals between LEVITRA intake and the start of intercoursedate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Reporting a second successful intercourse within 24 hours of dosingdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Patients prefer LEVITRA over last Erectile Dysfunction treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionNoSafety Issue: Tolerability of patients with LEVITRA treatmentdate_rangeTime Frame:After 6 monthsenhanced_encryptionYesSafety Issue: )]TJ /C2_0 1 Tf 0 Tc 0 Tw 7.98 0 0 7.98 49.405 366.8227 Tm <004A>Tj /TT1 1 Tf 12 0 0 12 52.705 361.3027 Tm ( )Tj /TT0 1 Tf 0.0001 Tc -0.0001 Tw 0.28 0 Td ( Flexible dose studies started all )Tj 0 Tc 0 Tw 13.055 0 Td [(patients at LEVITRA 10 m)7.8 (g)-5 ( and allo)]TJ -0.0002 Tc -0.0005 Tw 14.83 0 Td (wed decrease in dose to 5 mg or )Tj 0.0001 Tc -0.0001 Tw -27.66 -1.145 Td (increase in dose to 20 mg based on side effects and efficacy. )Tj 0 Tc -0.0006 Tw -0.78 -1.655 Td (Back pain was reported in 2.0% of patients treated)Tj 0 Tw ( with LEVITRA and 1.7% of patients on placebo. )Tj 0.0001 Tc -0.0026 Tw 0 -1.315 TD (Placebo-controlled trials suggested )Tj 0.0002 Tc -0.001 Tw 14.25 0 Td (a dose effect in the incidence of)Tj 0.0004 Tc -0.0016 Tw 12.71 0 Td [( som)8.2 (e)-0.8 ( adverse events \(headache, )]TJ -0.0003 Tw -26.96 -1.15 Td (flushing, dyspepsia, nausea, rhinitis\) over the )Tj 0.0001 Tc 0.0004 Tw 18.37 0 Td [(5 mg, 10 m)7.9 (g, and 20 m)7.9 (g doses of LEVITRA. The )]TJ 0.0008 Tc -0.0018 Tw -18.37 -1.15 Td [(f)3.8 (o)0.8 (llowing se)4.6 (ction identif)3.8 (i)-1.4 (es add)5.8 (ition)5.8 (a)4.6 (l, less f)3.8 (r)-1.2 (equ)5.8 (e)]TJ 0.001 Tc 19.99 0 Td [(nt events \(<)5 (2%\) repo)6 (rte)4.8 (d)1 ( during th)6 (e clin)6 (ical )]TJ 0.0006 Tc -0.002 Tw -19.99 -1.15 Td [(developm)8.4 (ent of LEVITRA.

ScriptSave WellRx

Excluded from)8.4 ( this list ar)]TJ -0.0027 Tw 21.44 0 Td [(e those events that are infrequ)5.6 (e)4.4 (nt and m)8.4 (i)-1.6 (nor, )]TJ 0.0003 Tc -0.0009 Tw -21.44 -1.145 Td [(those events that m)8.1 (a)-0.9 (y be commonly observed in the )]TJ 0.0001 Tc -0.0013 Tw (absence of drug therapy, a)Tj 0.0003 Tc -0.0015 Tw 31.49 0 Td (nd those events that are )Tj -0.0001 Tc 0.0001 Tw -31.49 -1.155 Td (not reasonably associated with the drug. )Tj 0 Tc 0.0037 Tw 1.5 -1.315 Td (BODY AS A WHOLE: anaphylactic)Tj 0.0008 Tc -0.0015 Tw 14.775 0 Td [( reaction \(in)5.8 (cluding lary)5.8 (ngeal edem)8.6 (a\), asthen)5.8 (ia, f)8.8 (ace edem)8.6 (a, )]TJ 0.0009 Tc 0 Tw -14.775 -2.3 Td (pain )Tj 0.0004 Tc -0.0004 Tw 0 -2.805 TD [(AUDITOR)-2.6 (Y)2.6 (: tinnitus )]TJ -0.0003 Tc 0.0003 Tw 0 -1.31 TD [(CARDIOVASCULAR:)-7.5 ( angina pectoris, ches)]TJ 0.0003 Tc -0.0003 Tw 18.11 0 Td [(t pain, hypertension, hypotension, m)8.1 (yocardial )]TJ 0.0005 Tc -0.0005 Tw -18.11 -1.155 Td [(ischem)8.3 (ia, myocardial inf)8.5 (a)-0.7 (rction, palpitation, )]TJ -0.0001 Tc 0.0001 Tw 17.97 0 Td (postural hypotension, s)Tj 0 Tc 0 Tw 9.245 0 Td (yncope, tachycardia )Tj 0.0002 Tc -0.0002 Tw -27.215 -1.31 Td [(DIGESTIVE: abdom)8 (inal pain, abnorm)8 (al liver f)]TJ -0.0027 Tw 18.88 0 Td [(unction tests, diarrhea, dry )-7.5 (m)8 (outh, dysphagia, )]TJ 0.0005 Tc -0.003 Tw -18.88 -1.155 Td [(esophagitis, gastritis, gas)4.7 (t)-1.7 (roesophag)5.5 (e)]TJ 0.0006 Tc -0.0006 Tw 14.83 0 Td [(al reflux, G)7.8 (G)2.8 (TP increas)4.8 (ed, vom)8.4 (iting )]TJ 0.0004 Tc -0.0004 Tw -14.83 -1.32 Td (MUSCULOSKELETAL: arthra)Tj 0.0005 Tc -0.0025 Tw 12.805 0 Td (lgia, back pain, myalgia, neck pain )Tj 0.0001 Tc -0.0017 Tw -12.805 -1.315 Td [(NERVOUS:)-7.1 ( hypertonia, hypesthesia, insom)7.9 (nia)]TJ 0.0002 Tc 18.855 0 Td [(, paresthesia, som)8 (nolence, vertigo )]TJ 0.0004 Tc -0.0004 Tw -18.855 -1.315 Td (RESPIRATORY: dyspnea, ep)Tj -0.0003 Tc 0.0003 Tw 12.09 0 Td (istaxis, pharyngitis )Tj 0 Tc 0.0016 Tw -12.09 -1.32 Td (SKIN AND APPENDAGES: photosensitivity)Tj 0.0002 Tc -0.0014 Tw 18.42 0 Td ( reaction, pruritus, rash, sweating )Tj ET q 1 0 0 1 -8.195038 -34.037292 cm /CS0 CS 0.004 0.004 0.004 SCN 0.75 w 1 j 1 J q 1 0 0 1 61.2 652.08 cm 0 0 m 432 0 l 0.48 -22.68 m 432.48 -22.68 l 0.48 -60.3 m 432.48 -60.3 l 0 -203.7 m 432 -203.7 l S Q Q /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 201 0 obj <>>>/Resources 234 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 202 0 obj <>>>/Resources 236 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 236 0 obj <> endobj 237 0 obj <> endobj 235 0 obj <>stream �5H�8CTzd#E���[��w���ᮆ�)ȼ�7�)��ࢠ1�97���8�������{�s ��~�N�4T$�C#A�}�A�_��r�y���XXm�d�=��jc����}�jˇX���(��? Proportion of vardenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm concentrationdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm countdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Proportion of sildenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo and vardenafil after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Washington, DC - The FDA gave approval yesterday to vardenafil (Levitra®, Bayer and Glaxo Smith Kline), an oral erectile-dysfunction drug that works through the same mechanism as sildenafil (Viagra®, Pfizer). Like sildenafil, vardenafil can seriously affect blood pressure and should not be taken by those on alpha blockers or nitrates. )Tj 0 Tc -0.0006 Tw -0.78 -1.655 Td (Back pain was reported in 2.0% of patients treated)Tj 0 Tw ( with LEVITRA and 1.7% of patients on placebo. )Tj 0.0001 Tc -0.0026 Tw 0 -1.315 TD (Placebo-controlled trials suggested )Tj 0.0002 Tc -0.001 Tw 14.25 0 Td (a dose effect in the incidence of)Tj 0.0004 Tc -0.0016 Tw 12.71 0 Td [( som)8.2 (e)-0.8 ( adverse events \(headache, )]TJ -0.0003 Tw -26.96 -1.15 Td (flushing, dyspepsia, nausea, rhinitis\) over the )Tj 0.0001 Tc 0.0004 Tw 18.37 0 Td [(5 mg, 10 m)7.9 (g, and 20 m)7.9 (g doses of LEVITRA.

Product	Dosage	Quantity + Bonus	Price
Levitra Generic	10mg	120 + 10 Pills	178.59€ 170.09€	Buy
Levitra Generic	20mg	60 + 6 Pills	131.11€ 124.87€	Buy
Levitra Generic	40mg	90 + 6 Pills	234.73€ 223.55€	Buy
Levitra Soft Tabs	20mg	90 + 6 Pills	241.31€ 229.82€	Buy
Levitra Soft Tabs	20mg	60 + 4 Pills	178.40€ 169.90€	Buy
Levitra Generic	40mg	270 + 10 Pills	561.89€ 535.13€	Buy
Levitra Generic	20mg	360 + 10 Pills	458.44€ 436.61€	Buy
Levitra Soft Tabs	20mg	20 Pills	74.68€ 71.12€	Buy
Levitra Generic	40mg	10 Pills	41.37€ 39.40€	Buy
Levitra Original	20mg	12 Pills	81.99€ 78.09€	Buy
Levitra Generic	60mg	180 + 10 Pills	501.43€ 477.55€	Buy
Levitra Professional	20mg	10 Pills	62.37€ 59.40€	Buy
Levitra Generic	10mg	180 + 10 Pills	246.74€ 234.99€	Buy
Levitra Generic	10mg	20 Pills	46.54€ 44.32€	Buy
Levitra Professional	20mg	180 + 4 Pills	502.31€ 478.39€	Buy
Levitra Generic	20mg	20 Pills	52.63€ 50.12€	Buy
Levitra Professional	20mg	20 Pills	101.00€ 96.19€	Buy

The )]TJ 0.0008 Tc -0.0018 Tw -18.37 -1.15 Td [(f)3.8 (o)0.8 (llowing se)4.6 (ction identif)3.8 (i)-1.4 (es add)5.8 (ition)5.8 (a)4.6 (l, less f)3.8 (r)-1.2 (equ)5.8 (e)]TJ 0.001 Tc 19.99 0 Td [(nt events \(<)5 (2%\) repo)6 (rte)4.8 (d)1 ( during th)6 (e clin)6 (ical )]TJ 0.0006 Tc -0.002 Tw -19.99 -1.15 Td [(developm)8.4 (ent of LEVITRA.

Dosing information

Top 5 tips for maintaining regulatory compliance in the pharmaceutical sector

Excluded from)8.4 ( this list ar)]TJ -0.0027 Tw 21.44 0 Td [(e those events that are infrequ)5.6 (e)4.4 (nt and m)8.4 (i)-1.6 (nor, )]TJ 0.0003 Tc -0.0009 Tw -21.44 -1.145 Td [(those events that m)8.1 (a)-0.9 (y be commonly observed in the )]TJ 0.0001 Tc -0.0013 Tw (absence of drug therapy, a)Tj 0.0003 Tc -0.0015 Tw 31.49 0 Td (nd those events that are )Tj -0.0001 Tc 0.0001 Tw -31.49 -1.155 Td (not reasonably associated with the drug. )Tj 0 Tc 0.0037 Tw 1.5 -1.315 Td (BODY AS A WHOLE: anaphylactic)Tj 0.0008 Tc -0.0015 Tw 14.775 0 Td [( reaction \(in)5.8 (cluding lary)5.8 (ngeal edem)8.6 (a\), asthen)5.8 (ia, f)8.8 (ace edem)8.6 (a, )]TJ 0.0009 Tc 0 Tw -14.775 -2.3 Td (pain )Tj 0.0004 Tc -0.0004 Tw 0 -2.805 TD [(AUDITOR)-2.6 (Y)2.6 (: tinnitus )]TJ -0.0003 Tc 0.0003 Tw 0 -1.31 TD [(CARDIOVASCULAR:)-7.5 ( angina pectoris, ches)]TJ 0.0003 Tc -0.0003 Tw 18.11 0 Td [(t pain, hypertension, hypotension, m)8.1 (yocardial )]TJ 0.0005 Tc -0.0005 Tw -18.11 -1.155 Td [(ischem)8.3 (ia, myocardial inf)8.5 (a)-0.7 (rction, palpitation, )]TJ -0.0001 Tc 0.0001 Tw 17.97 0 Td (postural hypotension, s)Tj 0 Tc 0 Tw 9.245 0 Td (yncope, tachycardia )Tj 0.0002 Tc -0.0002 Tw -27.215 -1.31 Td [(DIGESTIVE: abdom)8 (inal pain, abnorm)8 (al liver f)]TJ -0.0027 Tw 18.88 0 Td [(unction tests, diarrhea, dry )-7.5 (m)8 (outh, dysphagia, )]TJ 0.0005 Tc -0.003 Tw -18.88 -1.155 Td [(esophagitis, gastritis, gas)4.7 (t)-1.7 (roesophag)5.5 (e)]TJ 0.0006 Tc -0.0006 Tw 14.83 0 Td [(al reflux, G)7.8 (G)2.8 (TP increas)4.8 (ed, vom)8.4 (iting )]TJ 0.0004 Tc -0.0004 Tw -14.83 -1.32 Td (MUSCULOSKELETAL: arthra)Tj 0.0005 Tc -0.0025 Tw 12.805 0 Td (lgia, back pain, myalgia, neck pain )Tj 0.0001 Tc -0.0017 Tw -12.805 -1.315 Td [(NERVOUS:)-7.1 ( hypertonia, hypesthesia, insom)7.9 (nia)]TJ 0.0002 Tc 18.855 0 Td [(, paresthesia, som)8 (nolence, vertigo )]TJ 0.0004 Tc -0.0004 Tw -18.855 -1.315 Td (RESPIRATORY: dyspnea, ep)Tj -0.0003 Tc 0.0003 Tw 12.09 0 Td (istaxis, pharyngitis )Tj 0 Tc 0.0016 Tw -12.09 -1.32 Td (SKIN AND APPENDAGES: photosensitivity)Tj 0.0002 Tc -0.0014 Tw 18.42 0 Td ( reaction, pruritus, rash, sweating )Tj ET q 1 0 0 1 -8.195038 -34.037292 cm /CS0 CS 0.004 0.004 0.004 SCN 0.75 w 1 j 1 J q 1 0 0 1 61.2 652.08 cm 0 0 m 432 0 l 0.48 -22.68 m 432.48 -22.68 l 0.48 -60.3 m 432.48 -60.3 l 0 -203.7 m 432 -203.7 l S Q Q /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 201 0 obj <>>>/Resources 234 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA.

Optimal Use of Levitra Tablets

Currently, there have been no head-to-head trials comparing effectiveness of the three drugs. A fourth oral erectile-dysfunction drug, apomorphine (Uprima®, TAP Pharmaceuticals), has been approved in Europe, and TAP Pharmaceuticals applied to the FDA for its approval at the end of 2002. It is a dopamine receptor agonist and works through an entirely different mechanism. Although the drug received the support of an FDA advisory panel in April 2000 (as reported by heartwire ), TAP Pharmaceuticals withdrew apomorphine's new drug application soon after, due to concerns that it caused fainting spells. It resubmitted the drug late last year after further studies.

Patient assistance programs

Cite this: FDA approves new erectile dysfunction drug - Medscape - Aug 20, 2003. aDepartment of Urology and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, 77 Mitropoleos str., 546 22 Thessaloniki, Greece DOI: 10.1016/j.eururo.2004.01.014 External LinkAlso available on ScienceDirect External Link Vardenafil for Treatment of Men With Erectile Dysfunction: Efficacy and Safety in a Randomized, Double-Blind, Placebo-Controlled Trial Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study Influence of age on the efficacy and safety of vardenafil, a novel phosphodiesterase-5 inhibitor, for the treatment of erectile dysfunction The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction Achieving treatment optimization with sildenafil citrate (Viagra(R)) in patients with erectile dysfunction The potential value of erectile dysfunction inquiry and management Hellstrom, W. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 202 0 obj <>>>/Resources 236 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 236 0 obj <> endobj 237 0 obj <> endobj 235 0 obj <>stream �5H�8CTzd#E���[��w���ᮆ�)ȼ�7�)��ࢠ1�97���8�������{�s ��~�N�4T$�C#A�}�A�_��r�y���XXm�d�=��jc����}�jˇX���(��?

• Levitra 20 mg Bayer is a prescription medication for erectile dysfunction.
• It helps increase blood flow to facilitate an erection.
• The medication is taken about 30 minutes before sexual activity.
• Levitra 20 mg Bayer’s effects can last up to 4-5 hours.
• It belongs to a class called PDE5 inhibitors.
• Possible side effects include headaches, dizziness, and flushing.
• Do not use Levitra if you take nitrates or heart medications.
• Consult a healthcare provider before starting this medication.
• Levitra 20 mg Bayer should be stored in a cool, dry place.
• Do not exceed the prescribed dose to avoid adverse effects.
• Alcohol consumption can diminish the effectiveness of Levitra.

Proportion of vardenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm concentrationdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Mean sperm countdate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Proportion of sildenafil subjects with a 50% or greater decrease from baseline in mean sperm concentration at 6 months (LOCF), compared to placebo and vardenafil after repeated usedate_rangeTime Frame:24 weeksenhanced_encryptionyesSafety Issue: Washington, DC - The FDA gave approval yesterday to vardenafil (Levitra®, Bayer and Glaxo Smith Kline), an oral erectile-dysfunction drug that works through the same mechanism as sildenafil (Viagra®, Pfizer). Like sildenafil, vardenafil can seriously affect blood pressure and should not be taken by those on alpha blockers or nitrates.

See also:

The recommended dose is 10 mg taken one hour before sexual activity, with 20-, 5.0-, and 2.5-mg doses available. Vardenafil is a phosphodiesterase inhibitor and, like sildenafil, is strongly contraindicated if patients are taking nitrates (nitroglycerin tablets or patches) or alpha blockers, due to the possibility of a steep drop in blood pressure. Patients with QT prolongation are also advised not to take the drug, as there is a possibility of abnormal heart rhythm in these patients. The FDA warns that men whose underlying cardiovascular status makes sexual activity inadvisable should not take vardenafil. Patients who have suffered an MI or stroke within the last six months or have hypotension or hypertension, unstable angina, severe liver impairment, end-stage renal disease requiring dialysis, or retinitis pigmentosa should not take the drug.

Achieving treatment optimization with sildenafil citrate (Viagra(R)) in patients with erectile dysfunction

"Today's approval of Levitra means there is now an important alternative in the treatment of erectile dysfunction," said Colin J Foster, president, Bayer Pharmaceuticals Corporation, in a press release. The drug will be comarketed by Glaxo Smith Kline and Bayer, and Bloomberg News reports packaging will feature the "Levitra flame" levitra 20 brand to help distinguish the round orange pills from Viagra's now-famous blue diamond-shaped ones. Both drugs are likely to soon have a third competitor stateside. Eli Lilly & Co and Icos Corporation intend to introduce tadalafil (Cialis®), another phosphodiesterase inhibitor, to the US market later this year. Tadalafil and vardenafil have both been approved in Europe. The recommended dose is 10 mg taken one hour before sexual activity, with 20-, 5.0-, and 2.5-mg doses available. Vardenafil is a phosphodiesterase inhibitor and, like sildenafil, is strongly contraindicated if patients are taking nitrates (nitroglycerin tablets or patches) or alpha blockers, due to the possibility of a steep drop in blood pressure.

• Levitra 20 mg Bayer is designed for adult men with ED.
• It should be used with caution in patients with liver or kidney issues.
• The medication may cause visual disturbances in some users.
• Levitra 20 mg Bayer does not protect against sexually transmitted infections.
• Measuring your response can help determine proper dosage.
• Avoid taking Levitra if you have any known allergies to it.
• Some users report improved confidence after taking Levitra.
• The drug can sometimes cause a mild decrease in blood pressure.
• You should not crush or chew the tablets; swallow whole.
• Use medication only as prescribed by a healthcare professional.
• Levitra 20 mg Bayer is part of a broader class of ED treatments.

Patients with QT prolongation are also advised not to take the drug, as there is a possibility of abnormal heart rhythm in these patients. The FDA warns that men whose underlying cardiovascular status makes sexual activity inadvisable should not take vardenafil. Patients who have suffered an MI or stroke within the last six months or have hypotension or hypertension, unstable angina, severe liver impairment, end-stage renal disease requiring dialysis, or retinitis pigmentosa should not take the drug.

What other drugs will affect Levitra?

Pharmacotherapy for erectile dysfunction

"Today's approval of Levitra means there is now an important alternative in the treatment of erectile dysfunction," said Colin J Foster, president, Bayer Pharmaceuticals Corporation, in a press release. The drug will be comarketed by Glaxo Smith Kline and Bayer, and Bloomberg News reports packaging will feature the "Levitra flame" levitra 20 brand to help distinguish the round orange pills from Viagra's now-famous blue diamond-shaped ones. Both drugs are likely to soon have a third competitor stateside. Eli Lilly & Co and Icos Corporation intend to introduce tadalafil (Cialis®), another phosphodiesterase inhibitor, to the US market later this year. Tadalafil and vardenafil have both been approved in Europe.

Accessing Levitra in Malaysia

Currently, there have been no head-to-head trials comparing effectiveness of the three drugs. A fourth oral erectile-dysfunction drug, apomorphine (Uprima®, TAP Pharmaceuticals), has been approved in Europe, and TAP Pharmaceuticals applied to the FDA for its approval at the end of 2002. It is a dopamine receptor agonist and works through an entirely different mechanism. Although the drug received the support of an FDA advisory panel in April 2000 (as reported by heartwire ), TAP Pharmaceuticals withdrew apomorphine's new drug application soon after, due to concerns that it caused fainting spells.

Side Effect	Frequency	Severity	Advice
Headache	Common	Mild	Take analgesics if needed
Flushing	Common	Mild	Stay hydrated
Nasal congestion	Less common	Mild	Use decongestants if necessary
Dizziness	Less common	Mild	Sit or lie down immediately

It resubmitted the drug late last year after further studies. Cite this: FDA approves new erectile dysfunction drug - Medscape - Aug 20, 2003. aDepartment of Urology and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, 77 Mitropoleos str., 546 22 Thessaloniki, Greece DOI: 10.1016/j.eururo.2004.01.014 External LinkAlso available on ScienceDirect External Link Vardenafil for Treatment of Men With Erectile Dysfunction: Efficacy and Safety in a Randomized, Double-Blind, Placebo-Controlled Trial Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study Influence of age on the efficacy and safety of vardenafil, a novel phosphodiesterase-5 inhibitor, for the treatment of erectile dysfunction The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction Achieving treatment optimization with sildenafil citrate (Viagra(R)) in patients with erectile dysfunction The potential value of erectile dysfunction inquiry and management Hellstrom, W.